Oxaliplatin Other names: Oxaloplatine

Chemical formula: C₈H₁₂N₂O₄Pt  Molecular mass: 397.294 g/mol  PubChem compound: 6857599

Active ingredient description

Oxaliplatin is an antineoplastic active substance belonging to a new class of platinum-based compounds in which the platinum atom is complexed with 1,2-diaminocyclohexane (“DACH”) and an oxalate group.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
L01XA03 Oxaliplatin L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XA Platinum compounds
Discover more medicines within L01XA03

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
OXALIPLATIN Concentrate for solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 61825-94-3
DrugBank Drug: DB00526
KEGG Drug: D01790
PubChem Compound: 6857599
RxNorm Ingredient: 32592
SNOMED-CT Concept: 395814003
Oxaliplatin (substance)
UNII Identifier: 04ZR38536J
OXALIPLATIN

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.